Long-term results of coronary artery surgery

Coronary Artery Disease

Volumn 8, Issue 3-4, 1997, Pages 205-212

  Anderson, Jonathan R ^a   Parker, D John ^a,b  

^a MIDDLESEX HOSPITAL   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT;

AGE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; CORONARY RISK; DISEASE SEVERITY; FEMALE; GRAFT PATENCY; HEART EJECTION FRACTION; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REOPERATION; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SEX DIFFERENCE; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0031009722     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199703000-00012     Document Type: Review

References (70)

1. Kennedy JW, Kaiser GC, Fisher LD, Maynard C, Fritz JK, Myers W, et al.: Multivariate discriminate analysis of the clinical and angiographic predictors of operative mortality from the collaborative study in coronary artery surgery (CASS). J Thorac Cardiovasc Surg 1980, 80:876-887.
2. Coronary Artery Surgery Study (CASS) Investigators: Coronary artery surgery study (CASS): a randomised trial of coronary artery bypass surgery. Survival data. Circulation 1983, 68:939-950.
3. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group: Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984, 311:1333-1339.
4. Vasauskas E, European Coronary Surgery Study Group: Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med 1988, 319:332-337.
5. Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, Levin F, Schloss M: Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983, 68:785-795.
6. Cameron AAC, Davis KB, Rogers WJ: Recurrence of angina after coronary artery bypass surgery: predictors and prognosis (CASS Registry). J Am Coll Cardiol 1995, 26:895-899. A detailed discussion of the risk factors associated with angina recurrence after surgery.
7. Edmond M, Mock MB, Davis KB, Fisher LD, Holmes DR, Chaitman BR, et al.: Long term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 1994, 90:2645-2657
8. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W: A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI). N Engl J Med 1994, 331:1037-1043.
9. King SB, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MH, et al.: A randomized trial comparing coronary angioplasty with coronary bypass surgery: Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med 1994, 331:1044-1050.
10. Zhao XQ, Brown BG, Stewart DK, Hillger LA, Barnhart HX, Kosinski A, Weintraub WS, King SB III: Effectiveness of revascularization in the Emory Angioplasty versus Surgery Trial. A randomized comparison of coronary angioplasty with bypass surgery. Circulation 1996, 93:1954-1962.
11. The CABRI Trial Participants: First year results of CABRI (Coronary Angioplasty versus Bypass Revascularization Investigation). Lancet 1995, 346:1179-1184.
12. RITA Trial Participants: Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina Trial (RITA) trial. Lancet 1993, 341:573-580.
13. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators: Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996, 335:217-225. Patients with multivessel disease have similar mortality, whether treated by PTCA or by CABG.
14. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, et al.: Effect of coronary artery bypass graft surgery on survival: overview of 10 year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994, 344:563-570.
15. ••]).
16. Goy JJ, Eeckhout E, Burnand B, Vogt P, Stauffer JC, Hurni M, et al.: Coronary angioplasty versus left internal mammary artery grafting for isolated proximal left anterior descending artery stenosis. Lancet 1994, 343:1419-1453.
17. Hueb WA, Bellotti G, de Oliveira SA, Arie S, de Albuquerque CP, Jatene AD, Pileggi F: The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 1995, 26:1600-1605.
18. •].
19. Sharma GV, Deupree RH, Luchi RJ, Scott SM: Identification of unstable angina patients who have a favourable outcome with medical or surgical therapy (eight year follow-up of the Veterans Administration Cooperative Study). Am J Cardiol 1994, 74:454-458.
20. Scott SM, Deupree RH, Sharma GV, Luchi RJ: VA study of unstable angina: 10 year results show duration of surgical advantage for patients with impaired ejection fraction. Circulation 1994, 90 (suppl 2):120-123.
21. Jones RH, Kesler K, Phillips HR, Mark DB, Smith PK, Nelson CL, et al.: Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Cardiovasc Surg 1996, 111:1013-1025.
22. Risum O, Abdelnoor M, Svennevig JL, Levorstad K, Nitter-Hauge S: Risk factors of recurrent angina pectoris and of non-fatal myocardial infarction after coronary artery surgery. Eur J Cardiothorac Surg 1996, 10:173-178. A detailed account of the survival and functional benefit after surgery and a discussion of the risk factors for recurrent events.
23. Mickleborough LL, Maruyama H, Tagaki Y, Mohamed S, Sun Z, Ebisuzaki L: Results of revascularization in patients with severe left ventricular function. Circulation 1995, 92 (suppl 2):73-79.
24. Shapira I, Isakov A, Yakirevich V, Topilsky M: Long term results of coronary artery bypass surgery in patients with severely depressed left ventricular function. Chest 1995, 108:1546-1550.
25. Cleland JGF: The clinical course of heart failure and its modification by ACE inhibitors: insights from recent clinical trials. Eur Heart J 1994, 15:125-130.
26. Caracciolo EA, Davis KB, Sopko G, Kaiser GC, Corley SD, Schaff H, Taylor MA, Chaitman BR: Comparison of surgical and medical group survival in patients with left main coronary artery disease. Circulation 1995, 91:2325-2334.
27. Caracciolo EA, Davis KB, Sopko G, Kaiser GC, Corley SD, Schaff H, Taylor HA, Chaitman BR: Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Circulation 1995, 91:2335-2344.
28. Davis KB, Chaitman B, Ryan T, Bittner V, Kennedy JW: Comparison of 15 year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS registry study. J Am Coll Cardiol 1995, 25:1000-1009.
29. French JK, Scott DS, Whitlock RM, Nisbet HD, Vedder HD, Kerr AR, Smith WM: Late outcome after coronary artery bypass grafting in patients less than 40 years old. Circulation 1995, 92 (suppl 2):14-19. Improved results in the younger age group are associated with the use of the internal mammary artery, aspirin, lipid-lowering therapy, ACE inhibition, and strict diabetic control.
30. Peigh PS, Swartz MT, Vaca KJ: Effect of advancing age on cost and outcome of coronary artery bypass grafting. Ann Thorac Surg 1994, 58:1362-1366.
31. Kaul TK, Fields BL, Wyatt DA, Jones CR, Kahn DR: Angioplasty versus coronary artery bypass in octogenarians. Ann Thorac Surg 1994, 58:1419-1426.
32. Cane ME, Chen C, Bailey BM, Fernandez J, Laub GW, Anderson WA: CABG in octogenarians: early and late events and actuarial survival in comparison with a matched population. Ann Thorac Surg 1995, 60:1033-1037
33. Ladowski JS, Dillon TA, Deschner WP, DeRiso AJ, Peterson AC, Schatzlein MH: Durability of emergency coronary artery bypass for complications of failed angioplasty. Cardiovasc Surg 1996, 4:23-27. Surgery is associated with favourable results even in the emergency setting.
34. Kaul TK, Fields BL, Wyatt DA, Jones CR, Kahn DR: Surgical management in patients with coexistent coronary and cerebrovascular disease: long term results. Chest 1994, 106:1349-1357.
35. Kaul TK, Fields BL, Reddy MA, Kahn DR: Cardiac operations in patients with end-stage renal disease. Ann Thorac Surg 1994, 57:691-696.
36. Pocock SJ, Henderson RA, Seed P, Treasure T, Hampton JR: Quality of life, employment status, and anginal symptoms after coronary angioplasty or bypass surgery. Three year follow up in the Randomised Intervention Treatment of Angina (RITA) trial. Circulation 1996, 94:135-142.
37. Hatly MA, Rogers WJ, Johnstone I, Boothroyd D, Brooks MM, Pitt B, et al.: Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. N Engl J Med 1997, 336:92-99.
38. Ayanian JZ, Guadagnoli E, Clearly PD: Physical and psychosocial functioning of women and men after coronary artery bypass surgery. JAMA 1995, 274:1767-1770.
39. Kumar P, Zehr KJ, Chang A, Cameron DE, Baumgartner WA: Quality of life in octogenarians after open heart surgery. Chest 1995, 108:919-926.
40. Van Brussel BL, Plokker HK, Voors AA, Ernst JM, Ernst JM, Knaepen PJ, et al.: Multivariate risk factor analysis of clinical outcome 15 years after venous coronary artery bypass graft surgery. Eur Heart J 1995, 16:1200-1206. A review of 428 patients undergoing CABG with vein-graft only. The long-term results depend on well known preoperative factors and the presence of obesity and lipid abnormalities.
41. Puga J: The use of the left internal mammary artery for revascularization of the left anterior descending coronary artery. Eur Heart J 1995, 16:21-25.
42. Cameron AAC, Green GE, Brogno DA, Thornton J: Internal thoracic artery grafts: 20 year clinical follow up. J Am Coll Cardiol 1995, 25:188-192.
43. Noyez L, van der Werf T, Remmen GHJ, Kaan GL, Lacquet LK: Importance of the internal mammary artery for coronary artery bypass grafting in patients aged > 70 years. Am J Cardiol 1995, 75:734-736.
44. Cameron A, Davis KB, Green G, Schaff HV: Coronary bypass surgery with internal thoracic artery grafts: effects on survival over a fifteen year period. N Engl J Med 1996, 334:216-219. The long-term benefits of internal thoracic artery grafts are discussed.
45. Dewar LRS, Jamieson WRE, Janusz MT, Adeli-Sardo M, Germann E, MacNab JS, Tyers FO: Unilateral versus bilateral internal mammary revascularization. Circulation 1995, 92 (suppl 2):45-49.
46. Pym J, Brown P, Pearson M, Parker J: Right gastroepiploic-to-coronary artery bypass. The first decade of use. Circulation 1995, 92 (suppl 2): 45-49. A detailed description of this conduit by the pioneers of the technique.
47. Grandjean JG, Bookstra PW, Den Heyer P, Ebels T: Arterial revascularization with the right gastroepiploic artery and internal mammary arteries in 300 patients. J Thorac Cardiovasc Surg 1994, 107:1309-1315.
48. Buche M, Schroeder E, Gurne O, Chenu R Paquay JL, Marchandise B, et al.: Coronary artery bypass grafting with the inferior epigastric artery: mid term clinical and angiographic results. J Thorac Cardiovasc Surg 1995, 109:553-559.
49. Canver CC: Conduit options in coronary artery bypass surgery. Chest 1995, 108:1150-1155.
50. Cooper GJ, Underwood MJ, Deverall PB: Arterial and venous conduits for coronary artery bypass. A current review. Eur J Cardiothorac Surg 1996, 10:129-140. An up-to-date review of conduits used for CABG.
51. Kaul TJ, Fields BL, Wyatt DA, Jones CR, Kahn DR: Reoperative coronary artery bypass surgery: early and late results and management in 1300 patients. J Cardiovasc Surg 1995, 36:303-312. A large study outlining risk factors and results for reoperative coronary surgery. The use of the internal mammary artery in repeat CABG improves survival and freedom from cardiac events.
52. Weintraub WS, Jones EL, Craver JM, Grosswald R, Guyton RA: In hospital and long term outcome after reoperative coronary artery bypass graft surgery. Circulation 1995, 92 (suppl 2):50-57.
53. Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, et al.: Long term graft patency (3 years ) after coronary artery surgery. Effects of aspirin: results of a VA Cooperative study. Circulation 1994, 89:1138-1143.
54. Stein PD, Dalen JE, Goldman S, Schwartz L, Theroux P, Turpie AG: Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts. Chest 1995, 108 (suppl):424-430.
55. Bryan AJ, Angelini GD: The biology of saphenous vein graft occlusion: etiology and strategies for prevention. Curr Opin Cardiol 1994, 9:641-649.
56. Bourassa MG: Long term graft patency. Curr Opm Cardiol 1994, 9: 685-691.
57. Mills NL, Everson CT: Vein graft failure. Curr Opm Cardiol 1995, 10: 562-568.
58. Daida H, Yokoi H, Miyano H, Mokuno H, Satoh H, Kottke TE, Hosonda Y, Yamaguchi H: Relation of saphenous vein graft obstruction to serum cholesterol levels. J Am Coll Cardiol 1995, 25:193-197.
59. Kawasuji M, Sakakibara N, Takemura H, Matsumoto Y, Mabuchi H, Watanabe Y: Coronary artery bypass in familial hypercholesterolaemia. J Thorac Cardiovasc Surg 1995, 109:364-369.
60. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994, 344:1383-1389.
61. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al., for the Cholesterol and Recurrent Events Trial Investigators: The effect of pravastatin on coronary events afters after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996, 335:1001-1009. Cholesterol lowering in patients with proven ischaemic heart disease and average cholesterol concentrations results in fewer ischaemic events at 5-year follow-up. This has enormous healthcare implications.
62. Johannesson M, Jonsson B, Kjekshus J, Olson AG, Pedersen TR, Wedel H: Cost effectiveness of Simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. N Engl J Med 1997, 336:332-336.
63. Skinner JS, Farrer M, Albers CJ, Adams PC: Risk factor control five years after coronary bypass grafting. J R Coll Physicians Lond 1996, 30:136-141.
64. Northridge DB, Shandall A, Rees A, Buchalter MB: Inadequate management of hyperlipidaemia after coronary artery bypass surgery shown by medical audit. Br Heart J 1994, 72:466-467.
65. The Post Coronary Artery Bypass Graft Trial Investigators: The effect of aggressive lowering of low density lipoprotein cholesterol levels and low dose anticoagulation on obstructive changes in saphenous vein coronary artery bypass grafts. N Engl J Med 1997, 336:153-162.
66. Kimura T, Yokoi H, Nakagawa Y, Tamura T, Satoshi K, Sadawa Y, et al.: Three year follow up after implantation of metallic coronary artery stents. N Engl J Med 1996, 334:561-566.
67. Tan KH, Henderson RA, Sulke N, Cooke RA, Karani S, Sowton E: PTCA in patients with prior CABG: 10 years' experience. Catheter Cardiovasc Diag 1994, 32:11-17.
68. Wong SC, Baim DS, Schatz RA, Teirstein PS, King SB III, Curry RC Jr, et al.: Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study Group. J Am Coll Cardiol 1995, 26:704-712.
69. Hartmann JR, McKeever LS, O'Neill WW, White CJ, Whitlow PL, Gilmore PL, Gilmore PS, Doorey AJ, Galichia JP, Enger EL: Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts with long term, low dose, direct infusion of urokinase. J Am Coll Cardiol 1996, 27:60-66.
70. Benetti F, Mariana MA, Sani G, Boonstra PW, Grandjean JG, Giomarelli P, Toscana M: Video-assisted minimally invasive coronary operations without cardiopulmonary bypass, a multicentre study. J Thorac Cardiovasc Surg 1996, 112:1478-1484.